(Q39716681)

14 September 2017

title

Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines (English)

1 reference

14 September 2017

0 references

0 references

0 references

3

1 reference

14 September 2017

4

S R Durham

1 reference

14 September 2017

M T Krishna

1

1 reference

14 September 2017

P W Ewan

2

1 reference

14 September 2017

A J Frew

5

1 reference

14 September 2017

S C Leech

6

1 reference

14 September 2017

S M Nasser

7

1 reference

14 September 2017

British Society for Allergy and Clinical Immunology

8

1 reference

14 September 2017

publication date

1 September 2011

1 reference

Clinical & Experimental Allergy

14 September 2017

published in

1 reference

14 September 2017

volume

41

1 reference

14 September 2017

issue

9

1 reference

14 September 2017

page(s)

1201-1220

1 reference

Epidemiology of Hymenoptera allergy

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Diagnosis of Hymenoptera venom allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Epidemiology of insect venom sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Insect-venom allergy in Greek adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Hymenoptera stings in conscripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Natural history of Hymenoptera venom allergy in Eastern Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Prevalence and alternative therapy methods for bee and wasp allergy in Van.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Bee venom allergy in beekeepers and their family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Lessons for management of anaphylaxis from a study of fatal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Shortness of interval between two stings as risk factor for developing Hymenoptera venom allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Risk assessment in determining systemic reactivity to honeybee stings in sting-threatened individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Clinical and entomological factors influence the outcome of sting challenge studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

An epidemiologic study of insect allergy in children. I. Characteristics of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Cardiovascular disease and anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Safety of Angiotensin-converting enzyme inhibitors in patients with insect venom allergies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Fatal anaphylactic sting reaction in a patient with mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Distribution of vespid species in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Comparison of the allergenicity and antigenicity of Polistes venom and other vespid venoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

The frequency and clinical significance of specific IgE to both wasp (Vespula) and honey-bee (Apis) venoms in the same patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

[Cross-reactivity to honeybee and wasp venom].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Natural history of large local reactions from stinging insects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

A controlled trial of immunotherapy in insect hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

The value of immunotherapy with venom in children with allergy to insect stings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Studies of 400 Hymenoptera sting deaths in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Ocular lesions arising after stings by hymenopteran insects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Acute interstitial nephritis and pigmented tubulopathy in a patient after wasp stings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Hornet sting induced systemic allergic reaction and large local reaction with bulle formation and rhabdomyolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Diagnosis of Allergy to Stinging Insects by Skin Testing with Hymenoptera Venoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Assessing anaphylactic risk? Consider mast cell clonality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

High sensitivity of basophils predicts side-effects in venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Insect sting allergy with negative venom skin test responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Comparison of the venom immunogenicity of various species of yellow jackets (genus Vespula).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Determination of IgE antibodies to Polistes dominulus, Vespula germanica and Vespa crabro in sera of patients allergic to vespids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Selection of Hymenoptera venoms for immunotherapy on the basis of patient's IgE antibody cross-reactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Hyposensitisation treatment with pure bee venom (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Diagnosis and treatment of anaphylactic reactions to Hymenoptera stings in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Safety of Hymenoptera venom rush immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Regimens of Hymenoptera venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

A bronchodilator action of glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Survey of patients after discontinuing venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Fatal insect allergy after discontinuation of venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Investigational and clinical use of the sting challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Insect sting fatality 9 years after venom treatment (venom allergy, fatality).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

New insight into immunological mechanisms of venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Inhibition of IgE-induced activation of human mast cells by IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Early effect of ultrarush venom immunotherapy on the IgG antibody response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Prognosis of patients reacting with urticaria to insect sting. Results of an in-hospital sting challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

The incidence and nature of adverse reactions to injection immunotherapy in bee and wasp venom allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03788.X

10.1111/J.1365-2222.2011.03788.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference